Table 3 Univariate analysis of risk factors for DT in the training group
DT n = 160 | NDT n = 150 | p | |
|---|---|---|---|
Sex | 0.001 | ||
male | 47(29.4%) | 20(13.3%) | |
female | 113(70.6%) | 130(86.7%) | |
Age(y) | 45(32,52) | 50(39,57.25) | < 0.001 |
BMI (kg/cm2) | 24.55 ± 3.54 | 22.61 ± 2.58 | < 0.001 |
Thyroid volume(mL) | 13.19(9.59,19.01) | 10.04(8.09,11.64) | < 0.001 |
Blood flow of thyroid | 0.213 | ||
rich | 36(22.5%) | 43(28.7%) | |
normal | 124(77.5%) | 107(71.3%) | |
Tumor size(cm) | 0.95(0.59,1.70) | 0.85(0.59,1.53) | 0.732 |
Tumor location | 0.321 | ||
upper | 30(18.8%) | 25(16.7%) | |
middle | 95(59.4%) | 81(54.0%) | |
lower | 35(21.8%) | 44(29.3%) | |
Close to the capsule | 0.953 | ||
yes | 72(45.0%) | 68(45.3%) | |
no | 88(55.0%) | 82(54.7%) | |
Lesion | 0.425 | ||
unifocal | 47(29.4%) | 38 (25.3%) | |
multifocal | 113(70.6%) | 112(74.7%) | |
FNA | 0.200 | ||
yes | 69(43.1%) | 54(36.0%) | |
no | 91(56.9%) | 96(64.0%) | |
FT3(pg/mL) | 3.44(3.19,3.68) | 3.35(3.10,3.67) | 0.214 |
FT4 (ng/dL) | 1.15(1.06,1.30) | 1.18(1.07,1.28) | 0.866 |
TSH(μIU/mL) | 1.58(1.06,2.38) | 1.61(1.14,2.29) | 0.922 |
Tg-Ab(U/mL) | 20.45(15.00,133.13) | 20.35(10.10,34.65) | 0.003 |
TPO-Ab(U/mL) | 40.85(28.23,1135.98) | 36.10(25.28,51.30) | 0.001 |